These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16553524)

  • 21. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
    Warrington SJ
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.
    Weller EB; Tucker S; Weller RA
    Curr Psychiatry Rep; 2005 Apr; 7(2):87-90. PubMed ID: 15802083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy with selective serotonin reuptake inhibitors (SSRI). Indications, uses and risks].
    Ebert D
    Fortschr Med; 1996 Jul; 114(18-19):243-7. PubMed ID: 8766793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensory disturbances associated with serotonin reuptake inhibitors: brief review.
    Praharaj SK; Arora M; Sarkhel S
    Hum Psychopharmacol; 2010 Apr; 25(3):216-21. PubMed ID: 20373472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
    Cosci F; Chouinard G; Chouinard VA; Fava GA
    Riv Psichiatr; 2018; 53(2):95-99. PubMed ID: 29674777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors.
    Dobry Y; Rice T; Sher L
    Int J Adolesc Med Health; 2013; 25(3):193-9. PubMed ID: 24006318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefits exceed risks of newer antidepressant medications in youth--maybe not.
    Potter WZ
    Clin Pharmacol Ther; 2009 Oct; 86(4):357-9. PubMed ID: 19763114
    [No Abstract]   [Full Text] [Related]  

  • 28. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety.
    Kronenberg S; Frisch A; Rotberg B; Carmel M; Apter A; Weizman A
    Pharmacogenomics; 2008 Nov; 9(11):1725-36. PubMed ID: 19018726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.
    Stahl SM
    J Affect Disord; 1998 Dec; 51(3):215-35. PubMed ID: 10333979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants for functional gastrointestinal disorders in children.
    Tan E; Smith CH; Goldman RD
    Can Fam Physician; 2013 Mar; 59(3):263-4. PubMed ID: 23486795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits exceed risks of newer antidepressant medications in youth--maybe.
    March JS; Vitiello B
    Clin Pharmacol Ther; 2009 Oct; 86(4):355-7. PubMed ID: 19763113
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study.
    Donneyong MM; Bykov K; Bosco-Levy P; Dong YH; Levin R; Gagne JJ
    BMJ; 2016 Sep; 354():i5014. PubMed ID: 27694571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel psychotropic medications in children: new toxicities to master.
    Jacobs ES; Dickstein DP; Liebelt EL
    Pediatr Emerg Care; 2001 Jun; 17(3):226-31. PubMed ID: 11437154
    [No Abstract]   [Full Text] [Related]  

  • 36. Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases.
    Hergüner S; Kilinçaslan A; Görker I; Tüzün U
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):367-9. PubMed ID: 17630870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of selective serotonin reuptake inhibitors for the treatment of childhood panic disorder: a pilot study.
    Renaud J; Birmaher B; Wassick SC; Bridge J
    J Child Adolesc Psychopharmacol; 1999; 9(2):73-83. PubMed ID: 10461817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?
    Cohen D
    Psychother Psychosom; 2007; 76(1):5-14. PubMed ID: 17170559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dark side of SSRIs: selective serotonin reuptake inhibitors.
    Inott TJ
    Nurs Manage; 2009 Nov; 40(11):44-6. PubMed ID: 19901757
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective serotonin re-uptake inhibitors for children and adolescents.
    Ziervogel CF
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I20-6. PubMed ID: 11140777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.